This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Innovations of Ching-Hsuen Chu
Introduction
Ching-Hsuen Chu is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the area of acetyl CoA carboxylase.
Latest Patents
Ching-Hsuen Chu holds a patent for "Acetyl CoA carboxylase 2 sequences and methods." This invention relates to novel nucleotide and amino acid sequences, specifically focusing on human acetyl CoA carboxylase 2 (ACC2) and rat ACC2 sequences. The sequences can be expressed in a recombinant format, and methods for isolating the ACC2 sequence are also provided. These sequences have potential therapeutic applications for diagnosing or treating conditions associated with ACC2. Additionally, the invention includes the identification of modulators of ACC activity using the recombinant human ACC2 enzyme as a screening target. He has 1 patent to his name.
Career Highlights
Ching-Hsuen Chu is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and innovations in biochemistry. His work has implications for therapeutic developments in various medical conditions.
Collaborations
Ching-Hsuen Chu has collaborated with notable colleagues, including Dong Cheng and Luping Chen, who contribute to his research endeavors.
Conclusion
Ching-Hsuen Chu's innovative work in the field of acetyl CoA carboxylase has the potential to impact therapeutic applications significantly. His contributions reflect the importance of research and innovation in advancing medical science.